▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
▁issue 7.3828125
▁among 7.328125
▁at 6.82421875
▁least 1.4091796875
▁ 2.65234375
8 3.197265625
% 4.31640625
▁of 1.8486328125
▁the 1.236328125
▁residents 6.89453125
▁of 2.294921875
▁progress 9.4140625
ive 0.9912109375
▁countries 6.890625
. 2.107421875
▁The 2.505859375
▁introduction 7.234375
▁of 0.257568359375
▁the 1.609375
▁study 6.78515625
▁describes 8.03125
▁the 0.865234375
▁apparent 9.0703125
▁link 6.33203125
▁between 0.5322265625
▁pain 6.2734375
▁and 0.7470703125
▁d 5.7421875
▁em 14.5546875
oral 5.0
ization 1.7236328125
. 1.4736328125
▁Chron 5.7734375
ic 0.034515380859375
▁pain 0.494873046875
▁is 1.3046875
▁always 6.62890625
▁accompanied 2.806640625
▁by 0.079833984375
▁negative 5.203125
▁emot 1.455078125
ional 1.1865234375
▁experiences 2.91796875
▁and 2.11328125
▁blocks 10.65625
▁a 4.33203125
▁person 1.578125
’ 23.921875
s 1.7490234375
▁ability 1.568359375
▁to 0.05584716796875
▁receive 5.83203125
▁joy 5.171875
▁and 1.408203125
▁satisfaction 3.1171875
▁from 1.1279296875
▁life 1.154296875
. 0.33740234375
▁The 1.9169921875
▁research 4.1015625
▁investig 5.3125
ates 0.462158203125
▁the 0.490234375
▁development 5.96875
▁of 0.1883544921875
▁de 3.615234375
pression 0.6083984375
▁and 1.2587890625
▁anx 2.525390625
iety 0.01178741455078125
▁among 2.43359375
▁patients 2.2109375
▁receiving 4.3046875
▁ph 6.140625
arma 2.0703125
ce 0.0290069580078125
ut 0.0111846923828125
ical 0.01409149169921875
▁op 4.7265625
io 0.1773681640625
ids 0.6337890625
▁and 2.365234375
▁med 8.8359375
▁ 6.6796875
ical 0.7509765625
▁mar 0.79833984375
iju 0.08953857421875
ana 0.0015020370483398438
▁( 4.27734375
MM 0.5654296875
) 3.029296875
▁as 2.80078125
▁severe 9.890625
▁pain 1.6103515625
kill 3.4296875
ers 0.00753021240234375
. 0.53125
▁It 3.28515625
▁comp 5.24609375
ares 0.047760009765625
▁the 0.66845703125
▁effic 6.34375
acy 0.01654052734375
▁of 0.247802734375
▁pres 4.97265625
cri 1.9208984375
ptions 1.4130859375
▁and 2.490234375
▁exam 5.59765625
ines 0.019866943359375
▁the 0.47412109375
▁possibility 3.833984375
▁of 0.0965576171875
▁post 7.0546875
- 0.8828125
tre 2.49609375
at 0.0177154541015625
ment 0.052947998046875
▁de 2.046875
pression 0.244384765625
. 1.7919921875
<0x0A> 2.62890625
There 4.9296875
▁is 1.091796875
▁currently 4.50390625
▁a 1.2001953125
▁sever 10.2421875
el 7.35546875
ack 2.626953125
▁of 0.053497314453125
▁information 2.35546875
▁about 1.4130859375
▁the 0.496337890625
▁effects 3.0078125
▁of 0.07122802734375
▁op 1.7099609375
i 3.529296875
ates 0.51904296875
. 4.140625
▁They 4.8046875
▁manage 9.171875
▁pain 3.1171875
▁successfully 5.9140625
, 1.01171875
▁but 0.37841796875
▁the 2.736328125
▁past 9.4375
▁few 2.998046875
▁dec 0.8427734375
ades 0.0025539398193359375
▁indicated 8.8828125
▁the 2.01171875
▁growing 4.5703125
▁concern 3.392578125
▁regarding 2.884765625
▁op 3.462890625
iate 0.68408203125
▁ab 1.4658203125
use 0.01229095458984375
▁in 3.431640625
▁forms 10.546875
▁of 0.309814453125
▁over 3.251953125
d 0.433837890625
ose 0.1883544921875
▁and 0.7236328125
▁add 1.1171875
iction 0.03460693359375
. 0.2327880859375
▁A 4.03515625
▁more 5.84765625
▁manage 9.0
able 0.0193328857421875
▁and 2.248046875
▁sa 2.35546875
fer 0.002147674560546875
▁alternative 1.7060546875
▁might 6.46484375
▁be 0.17822265625
▁medical 3.728515625
▁mar 0.1292724609375
iju 0.0194244384765625
ana 0.00443267822265625
. 1.5361328125
▁However 2.98046875
, 0.01364898681640625
▁the 1.6259765625
▁legal 4.25
▁status 1.26953125
▁and 2.765625
▁novel 9.390625
ty 0.6943359375
▁of 0.2027587890625
▁this 1.5966796875
▁drug 2.00390625
▁do 4.9375
▁not 0.0819091796875
▁allow 1.0537109375
▁finding 8.796875
▁a 2.361328125
▁large 4.17578125
▁number 1.2978515625
▁of 0.008392333984375
▁studies 1.3955078125
▁on 1.5537109375
▁its 0.947265625
▁effect 2.0859375
iveness 0.408935546875
. 1.0595703125
▁Specifically 8.34375
, 0.12548828125
▁it 2.728515625
▁concerns 4.6953125
▁the 0.673828125
▁emot 7.51171875
ional 0.0189056396484375
▁condition 5.41015625
▁of 0.406005859375
▁patients 0.72705078125
▁experien 6.421875
cing 0.0012302398681640625
▁chron 1.2939453125
ic 0.0047607421875
▁pain 0.10357666015625
. 0.71630859375
▁This 3.080078125
▁research 2.859375
▁paper 6.34765625
▁a 2.171875
ims 0.0015668869018554688
▁to 0.1285400390625
▁analyze 3.123046875
▁levels 9.7578125
▁of 0.0369873046875
▁de 0.54150390625
pression 0.06353759765625
▁and 0.263427734375
▁anx 0.052764892578125
iety 0.0040130615234375
▁among 0.70458984375
▁people 3.310546875
▁receiving 0.8828125
▁ther 7.86328125
apy 0.40185546875
▁by 5.17578125
▁comparing 8.3125
▁the 1.00390625
▁effects 2.130859375
▁of 0.02996826171875
▁ph 2.505859375
arma 0.0552978515625
ce 0.00557708740234375
ut 0.00222015380859375
ical 0.004322052001953125
▁op 0.259765625
io 0.1864013671875
ids 0.061676025390625
▁and 0.2666015625
▁MM 1.1474609375
. 1.134765625
<0x0A> 1.119140625
The 1.412109375
▁study 2.166015625
▁was 2.240234375
▁conducted 0.79052734375
▁in 1.529296875
▁the 1.4208984375
▁form 2.251953125
▁of 0.01479339599609375
▁collection 9.9375
▁and 1.6826171875
▁analysis 0.65966796875
▁of 0.0423583984375
▁statistical 4.14453125
▁data 0.122802734375
. 0.91650390625
▁Part 4.890625
icip 0.0782470703125
ants 0.057952880859375
▁were 0.76904296875
▁rec 3.439453125
ru 0.0028705596923828125
ited 0.001018524169921875
▁for 4.11328125
▁six 7.6484375
▁months 0.5390625
▁at 3.744140625
▁two 2.5703125
▁major 5.5078125
▁pain 3.173828125
▁relief 5.30859375
▁cent 1.4921875
ers 0.095458984375
▁in 0.69482421875
▁Israel 4.640625
. 0.435546875
▁The 1.193359375
▁research 2.138671875
ers 1.5576171875
▁used 2.673828125
▁The 7.8671875
▁De 4.234375
pression 0.0214691162109375
▁Module 10.0546875
▁of 0.94873046875
▁the 0.326904296875
▁Pat 2.3203125
ient 0.00862884521484375
▁Health 0.089599609375
▁Question 0.0191497802734375
naire 0.028167724609375
▁and 3.400390625
▁the 0.724609375
▁General 1.947265625
ized 0.7744140625
▁An 0.016876220703125
x 0.0007758140563964844
iety 0.004444122314453125
▁Dis 0.57275390625
order 0.040130615234375
▁Sc 1.2353515625
ale 0.0960693359375
▁to 1.7939453125
▁interview 7.07421875
▁participants 1.982421875
, 3.619140625
▁evaluate 5.71875
▁their 0.75439453125
▁answers 6.61328125
, 0.853515625
▁and 0.150146484375
▁conduct 4.49609375
▁the 2.255859375
▁study 2.29296875
. 0.2216796875
▁To 5.11328125
▁specifically 10.015625
▁evaluate 2.5
▁and 4.35546875
▁compare 0.95849609375
▁the 0.349609375
▁prob 10.9609375
abilities 0.2294921875
▁of 0.13037109375
▁de 0.8076171875
pression 0.043487548828125
▁or 4.55078125
▁anx 0.047027587890625
iety 0.00153350830078125
▁among 1.62890625
▁the 2.33203125
▁diverse 8.8828125
▁groups 1.61328125
, 1.509765625
▁the 1.0068359375
▁study 2.771484375
▁used 1.5751953125
▁multiple 4.71484375
▁log 2.783203125
istic 0.04071044921875
▁regression 0.1044921875
▁analysis 0.671875
▁and 2.564453125
▁chose 8.90625
▁medical 7.6015625
▁mar 0.250244140625
iju 0.007511138916015625
ana 0.0016736984252929688
▁as 0.80419921875
▁the 1.0703125
▁control 2.806640625
▁group 0.583984375
. 0.294189453125
<0x0A> 0.7900390625
This 3.43359375
▁type 6.00390625
▁of 0.0101165771484375
▁study 1.767578125
▁is 1.2216796875
▁the 3.41015625
▁most 1.83984375
▁reve 9.09375
aling 0.002960205078125
▁and 1.0556640625
▁inclus 6.4765625
ive 0.004726409912109375
, 2.255859375
▁as 1.921875
▁it 0.346923828125
▁contains 4.90234375
▁direct 6.36328125
▁responses 4.94140625
▁from 0.81005859375
▁a 3.865234375
▁large 0.94677734375
▁number 0.435302734375
▁of 0.0044097900390625
▁participants 1.4755859375
. 0.66357421875
▁All 4.64453125
▁tools 9.25
▁in 4.48046875
▁the 0.6689453125
▁form 3.529296875
▁of 0.040069580078125
▁question 1.7177734375
na 0.0321044921875
ires 0.0006551742553710938
▁and 2.07421875
▁scales 3.138671875
▁have 3.646484375
▁already 4.49609375
▁been 0.1705322265625
▁used 1.9453125
▁and 2.123046875
▁proved 4.21875
▁their 1.7470703125
▁effic 3.84375
acy 0.0004425048828125
▁for 3.64453125
▁collect 4.61328125
ing 0.0167999267578125
▁analyt 8.234375
ical 0.249755859375
▁data 0.269775390625
. 0.42822265625
▁It 3.578125
▁helps 4.78125
▁to 0.908203125
▁system 7.3125
at 1.1845703125
ize 0.0161895751953125
▁and 1.609375
▁class 4.05859375
ify 0.0031261444091796875
▁distinct 9.2421875
▁kinds 6.2109375
▁of 0.0247802734375
▁information 3.455078125
▁for 3.904296875
▁subsequent 4.08203125
▁un 7.98828125
comp 5.421875
licated 0.07757568359375
▁services 11.6875
. 0.666015625
▁Thus 4.3359375
, 0.0247955322265625
▁research 4.50390625
ers 0.51513671875
▁can 1.3408203125
▁compare 4.02734375
▁the 0.96435546875
▁effects 3.02734375
▁of 0.10260009765625
▁medic 4.27734375
ations 0.8037109375
▁on 1.7802734375
▁patients 2.138671875
▁of 4.5546875
▁diverse 3.908203125
▁age 2.65234375
▁groups 0.69091796875
, 0.91845703125
▁background 5.0390625
s 0.21337890625
, 0.071044921875
▁physical 5.43359375
▁conditions 1.4013671875
, 0.08807373046875
▁emot 5.296875
ional 0.066650390625
▁states 1.3505859375
, 0.10382080078125
▁and 0.43896484375
▁so 3.189453125
▁on 0.31005859375
. 0.095703125
<0x0A> 0.68212890625
The 1.1015625
▁analysis 4.58984375
▁of 0.54150390625
▁any 8.734375
▁human 6.0859375
▁reaction 4.7734375
▁has 4.54296875
▁a 1.748046875
▁high 4.48828125
▁potential 3.388671875
▁of 1.6396484375
▁subject 6.1796875
iveness 3.8203125
▁and 1.330078125
▁bias 2.234375
, 1.875
▁especially 2.48828125
▁regarding 4.375
▁people 4.53125
▁in 3.9609375
▁severe 4.23046875
▁pain 0.27978515625
▁and 2.634765625
▁un 5.40234375
stable 1.828125
▁emot 0.779296875
ional 0.1751708984375
▁condition 2.46484375
. 0.07891845703125
▁Perhaps 8.921875
▁some 5.015625
▁patients 2.404296875
▁tend 5.45703125
▁to 0.0231475830078125
▁ex 2.55859375
agger 0.001903533935546875
ate 0.007068634033203125
▁their 0.74609375
▁de 5.05078125
press 1.6240234375
ive 0.289794921875
▁state 3.13671875
▁or 1.8310546875
▁vice 7.44921875
▁vers 0.0165863037109375
a 0.00032711029052734375
, 0.99560546875
▁de 7.54296875
- 4.34765625
emph 0.87841796875
as 0.006656646728515625
ize 0.126953125
▁serious 6.69140625
▁difficulties 5.9453125
. 0.90625
▁Because 6.19921875
▁the 2.341796875
▁survey 6.140625
▁responses 6.703125
▁were 1.62890625
▁thoroughly 7.94921875
▁anonymous 5.265625
, 0.4541015625
▁the 1.453125
▁research 1.494140625
ers 0.271240234375
▁were 1.4619140625
▁unable 2.46875
▁to 0.00782012939453125
▁carefully 8.765625
▁analyze 1.5888671875
▁each 3.958984375
▁patient 2.55859375
’ 26.984375
s 0.91650390625
▁reaction 3.630859375
▁and 2.396484375
▁compare 3.48828125
▁it 0.8623046875
▁to 1.2744140625
▁the 0.75732421875
▁actual 5.7265625
▁states 7.26953125
▁of 0.7060546875
▁condition 7.1953125
. 0.39501953125
▁More 6.8515625
▁accurate 3.912109375
▁answers 4.69140625
▁could 2.4921875
▁be 0.88134765625
▁obtained 0.984375
▁by 1.376953125
▁professional 7.421875
▁psych 2.177734375
olog 0.32275390625
ists 0.0026569366455078125
▁via 8.046875
▁personal 3.939453125
▁communication 4.68359375
▁and 1.84765625
▁behavior 7.18359375
al 0.329833984375
▁analysis 2.2734375
. 0.228759765625
▁However 2.712890625
, 0.0028743743896484375
▁this 1.953125
▁method 2.822265625
▁of 2.271484375
▁research 2.1328125
▁is 0.9375
▁way 7.9140625
▁more 1.607421875
▁resource 6.59375
- 0.469482421875
int 0.57568359375
ensive 0.0094451904296875
▁and 0.6279296875
▁energy 8.6484375
- 0.1282958984375
consum 0.307861328125
ing 0.002651214599609375
. 0.60791015625
<0x0A> 0.64111328125
Part 5.53125
icip 0.09588623046875
ants 0.127197265625
▁were 1.0263671875
▁rec 1.5908203125
ru 0.0017881393432617188
ited 0.0003814697265625
▁for 1.130859375
▁six 1.1845703125
▁months 0.02398681640625
▁at 0.45166015625
▁two 0.11358642578125
▁major 0.351318359375
▁pain 0.03485107421875
▁relief 0.0268402099609375
▁cent 0.0292205810546875
ers 0.0102081298828125
▁in 0.061248779296875
▁Israel 0.031646728515625
. 0.1514892578125
▁All 3.48828125
▁patients 1.6162109375
▁experienced 5.51171875
▁chron 1.984375
ic 0.0031833648681640625
▁pain 0.1011962890625
▁for 3.365234375
▁at 0.7451171875
▁least 0.00179290771484375
▁ 1.1259765625
3 1.4287109375
▁months 0.2225341796875
. 1.0322265625
▁The 1.4521484375
▁study 1.9599609375
▁included 2.130859375
▁ 1.1201171875
8 2.8828125
9 2.77734375
0 3.560546875
▁participants 1.5302734375
, 1.2412109375
▁of 1.7724609375
▁which 0.41357421875
▁ 0.1385498046875
4 1.6435546875
7 2.466796875
4 2.7734375
▁( 2.142578125
5 0.09661865234375
9 11.1484375
%) 1.0322265625
▁were 0.46240234375
▁treated 4.68359375
▁sole 7.03125
ly 0.0002313852310180664
▁with 0.48486328125
▁op 0.7880859375
io 0.383056640625
ids 0.176513671875
, 1.1083984375
▁ 0.564453125
3 1.11328125
2 2.103515625
9 2.5234375
▁( 0.04254150390625
4 1.1796875
1 1.2607421875
%) 0.1329345703125
▁were 1.2822265625
▁treated 0.5078125
▁with 0.1785888671875
▁MM 0.79150390625
, 0.236083984375
▁and 0.14453125
▁ 0.1429443359375
7 3.208984375
7 2.423828125
▁( 0.1737060546875
8 3.828125
. 1.1318359375
6 2.98828125
%) 0.056640625
▁acquired 9.578125
▁both 1.138671875
▁( 6.95703125
Fe 10.1640625
ing 2.701171875
old 0.0243072509765625
▁et 1.4189453125
▁al 0.0220947265625
., 0.324462890625
▁ 0.01297760009765625
2 0.147705078125
0 0.0006647109985351562
1 0.40283203125
7 2.099609375
). 0.1322021484375
▁The 1.318359375
▁remaining 7.02734375
▁ten 8.15625
▁participants 1.35546875
▁who 5.58984375
▁did 1.4501953125
▁not 0.01036834716796875
▁receive 1.7939453125
▁ph 3.08203125
arma 0.050628662109375
ce 0.00272369384765625
ut 0.0002593994140625
ical 0.0034122467041015625
▁op 0.958984375
io 0.07659912109375
ids 0.0208892822265625
▁and 1.666015625
▁medical 3.740234375
▁mar 0.040985107421875
iju 0.006805419921875
ana 0.00015246868133544922
▁were 1.212890625
▁with 6.01953125
dra 0.178466796875
wn 0.0003058910369873047
▁from 0.251708984375
▁the 0.10784912109375
▁analysis 4.640625
▁in 4.8046875
▁the 1.18359375
▁research 4.25
. 0.73974609375
▁Therefore 4.7734375
, 0.0077972412109375
▁it 3.78125
▁is 0.8818359375
▁not 2.662109375
▁possible 0.69677734375
▁to 0.0208892822265625
▁compreh 6.46875
ens 0.052093505859375
ively 0.01418304443359375
▁compare 1.927734375
▁patients 4.78515625
▁taking 4.296875
▁medic 3.802734375
ations 0.4140625
▁with 0.98388671875
▁those 1.1904296875
▁who 1.11328125
▁do 1.7099609375
▁not 0.00905609130859375
. 0.79638671875
<0x0A> 0.65185546875
The 1.107421875
▁study 1.740234375
▁conducted 4.7421875
▁a 2.169921875
▁correlation 5.921875
▁type 7.41015625
▁of 0.431884765625
▁research 1.9873046875
▁with 2.8203125
▁variable 8.0390625
▁measures 4.5859375
. 1.2666015625
▁It 2.115234375
▁evaluated 4.390625
▁the 0.57080078125
▁inter 6.2421875
dep 3.625
end 0.0010280609130859375
ence 0.01324462890625
▁of 0.56396484375
▁various 3.859375
▁factors 1.6484375
▁that 2.830078125
▁affected 4.14453125
▁the 0.59423828125
▁physical 6.9296875
▁and 0.94921875
▁emot 0.44384765625
ional 0.0004696846008300781
▁condition 0.98681640625
▁of 0.10919189453125
▁patients 0.60205078125
▁experien 4.1640625
cing 0.00012385845184326172
▁chron 0.583984375
ic 0.0006160736083984375
▁pain 0.027374267578125
. 0.2244873046875
▁For 3.861328125
▁example 1.1044921875
, 0.015106201171875
▁the 1.2119140625
▁survey 5.1328125
▁showed 3.296875
▁that 0.41064453125
▁the 1.7353515625
▁ratio 6.98828125
▁of 0.12139892578125
▁female 4.51953125
▁patients 0.78515625
▁was 1.873046875
▁remark 9.5078125
ably 0.001407623291015625
▁higher 0.5234375
▁in 2.712890625
▁the 0.99853515625
▁op 4.65234375
i 3.939453125
ates 0.1304931640625
▁group 0.27734375
▁compared 2.76171875
▁to 0.12188720703125
▁the 0.51953125
▁MM 0.494140625
▁group 0.282958984375
. 0.5
▁In 2.966796875
▁turn 4.0625
, 0.0033550262451171875
▁people 5.9921875
▁on 5.49609375
▁op 1.404296875
i 0.4384765625
ates 0.004131317138671875
▁were 1.0458984375
▁more 0.95849609375
▁likely 0.38720703125
▁to 0.061187744140625
▁report 3.1171875
▁major 6.04296875
▁de 0.39697265625
press 1.21875
ive 0.0042266845703125
▁dis 0.466064453125
orders 1.4189453125
. 1.802734375
<0x0A> 2.5
The 1.107421875
▁question 5.63671875
na 1.1767578125
ires 0.00041222572326660156
▁used 2.017578125
▁different 8.21875
▁variable 8.734375
▁measures 0.7802734375
▁to 1.384765625
▁collect 2.359375
▁information 1.9150390625
. 1.63671875
▁For 2.015625
▁example 0.1982421875
, 0.007434844970703125
▁it 4.07421875
▁included 2.43359375
▁compreh 8.59375
ensive 0.0279388427734375
▁so 6.875
cio 0.040771484375
- 0.45458984375
dem 0.09283447265625
ographic 0.03680419921875
▁data 1.0166015625
: 4.87890625
▁gender 1.6044921875
, 0.091552734375
▁age 0.19677734375
, 0.0906982421875
▁country 4.3984375
, 1.4853515625
▁type 4.328125
▁of 0.056396484375
▁residence 3.828125
▁( 3.45703125
urban 2.03125
/ 2.966796875
r 0.06671142578125
ural 0.0011138916015625
), 0.2379150390625
▁years 5.94140625
▁of 0.16650390625
▁education 0.70751953125
, 0.151123046875
▁and 1.841796875
▁employ 3.689453125
ment 0.004833221435546875
▁status 0.449951171875
. 0.1807861328125
▁Pat 4.13671875
ients 0.09423828125
▁were 1.1640625
▁also 0.90283203125
▁asked 0.6318359375
▁about 1.1455078125
▁their 0.59814453125
▁medical 2.740234375
▁history 0.393310546875
▁over 8.796875
▁the 0.16015625
▁years 4.00390625
▁and 1.8115234375
▁the 1.8466796875
▁current 3.384765625
▁presence 5.8125
▁of 0.05352783203125
▁any 2.671875
▁severe 4.625
▁dise 1.439453125
ases 0.00014078617095947266
▁such 4.16796875
▁as 0.004974365234375
▁heart 2.408203125
▁failure 1.998046875
, 0.179931640625
▁di 1.8359375
ab 0.00229644775390625
etes 0.00467681884765625
, 0.124755859375
▁ar 3.76953125
th 0.13720703125
rit 0.036163330078125
is 0.01222991943359375
, 0.040924072265625
▁and 1.57421875
▁so 0.740234375
▁on 0.031005859375
. 0.051483154296875
▁The 1.86328125
▁third 7.21875
▁measure 3.9140625
▁of 2.06640625
▁the 0.9931640625
▁question 2.75
naire 0.180419921875
▁was 0.98876953125
▁indicated 9.6875
▁by 0.6064453125
▁information 6.51953125
▁on 1.5791015625
▁any 5.35546875
▁twelve 13.5859375
- 1.1533203125
month 0.35498046875
▁and 5.80078125
▁lifetime 3.150390625
▁drug 4.55078125
▁and 3.49609375
▁alco 0.0762939453125
hol 0.0001379251480102539
▁consumption 2.578125
. 0.467529296875
▁In 3.474609375
▁addition 0.80859375
, 0.125244140625
▁the 1.1494140625
▁record 7.875
▁included 1.73828125
▁a 2.48828125
▁pain 6.42578125
▁measurement 4.30859375
▁scale 1.025390625
▁from 3.634765625
▁ 0.4580078125
0 0.4638671875
▁to 0.407958984375
▁ 0.00785064697265625
1 0.08856201171875
0 0.07098388671875
▁to 4.60546875
▁evaluate 1.5185546875
▁dis 5.90625
com 0.177978515625
fort 0.0019407272338867188
▁feelings 7.375
▁during 3.283203125
▁the 0.8955078125
▁last 1.4326171875
▁month 1.5703125
. 0.286376953125
<0x0A> 1.142578125
Am 6.9140625
ong 0.01220703125
▁all 2.400390625
▁participants 1.984375
▁in 3.568359375
▁the 0.1695556640625
▁study 0.38623046875
, 0.054046630859375
▁ 0.6708984375
4 1.7685546875
2 2.72265625
. 1.8095703125
2 2.302734375
% 0.1435546875
▁suffered 4.875
▁from 0.13623046875
▁de 1.748046875
pression 0.1947021484375
, 1.0703125
▁and 1.7451171875
▁ 0.1436767578125
3 1.716796875
7 2.232421875
% 2.720703125
▁experienced 2.306640625
▁excess 7.81640625
ive 0.08721923828125
▁anx 0.267822265625
iety 0.0018968582153320312
. 0.351318359375
▁The 1.3984375
▁pl 11.171875
ur 1.033203125
ality 0.0002491474151611328
▁of 0.191650390625
▁de 3.53515625
press 1.2978515625
ive 0.026092529296875
▁dis 1.81640625
orders 0.058349609375
▁among 3.73828125
pat 13.1484375
ients 0.005947113037109375
▁in 3.849609375
▁the 0.421142578125
▁op 1.35546875
i 0.97509765625
ates 0.00762176513671875
, 6.9453125
▁medical 3.181640625
▁mar 0.0237884521484375
iju 0.013885498046875
ana 0.00032448768615722656
, 0.11248779296875
▁and 0.06939697265625
▁mixed 5.9609375
▁OP 8.9296875
MM 5.8671875
▁groups 0.49755859375
▁number 7.9375
ed 0.011016845703125
▁ 0.132568359375
5 2.2109375
7 2.498046875
. 0.2115478515625
1 2.361328125
%, 0.2442626953125
▁ 0.00843048095703125
2 2.958984375
2 2.423828125
. 0.10418701171875
3 2.240234375
%, 0.112548828125
▁and 0.034332275390625
▁ 0.00728607177734375
5 3.248046875
1 2.61328125
. 0.1732177734375
4 2.14453125
%, 0.379150390625
▁respectively 0.0131378173828125
. 0.30712890625
▁The 1.4345703125
▁pl 4.54296875
ur 0.0212554931640625
ality 6.020069122314453e-05
▁of 0.04461669921875
▁anx 0.9130859375
iety 0.01384735107421875
▁contained 11.171875
▁ 0.5712890625
4 1.580078125
8 2.376953125
. 0.06439208984375
4 2.302734375
% 0.505859375
▁among 1.5517578125
▁OP 6.42578125
▁patients 8.8359375
, 0.2744140625
▁ 0.09295654296875
2 1.4677734375
1 2.416015625
. 0.1300048828125
5 2.423828125
% 0.01171875
▁among 0.451416015625
▁MM 0.337646484375
▁patients 0.239013671875
, 0.01297760009765625
▁and 0.0138397216796875
▁ 0.040008544921875
3 1.244140625
8 2.6484375
. 0.1563720703125
7 2.287109375
% 0.0137481689453125
▁among 0.24755859375
▁OP 4.125
MM 0.248779296875
▁participants 3.666015625
. 0.233154296875
▁Pat 5.7421875
ients 0.0237274169921875
▁who 2.43359375
▁took 2.943359375
▁strong 8.203125
▁op 1.2294921875
i 1.400390625
ates 0.0045013427734375
▁were 1.775390625
▁t 8.890625
ended 1.2197265625
▁to 0.01537322998046875
▁place 10.3125
▁their 3.697265625
▁pain 2.615234375
▁on 3.408203125
▁a 0.87451171875
▁scale 2.279296875
▁of 0.6435546875
▁ 0.33447265625
9 2.8046875
▁to 1.3427734375
▁ 0.017303466796875
1 0.0234527587890625
0 0.09136962890625
▁( 2.501953125
Fe 1.630859375
ing 0.00968170166015625
old 0.0007882118225097656
▁et 0.0281219482421875
▁al 0.002788543701171875
., 0.00792694091796875
▁ 0.00850677490234375
2 0.0005702972412109375
0 6.747245788574219e-05
1 0.0020427703857421875
7 0.013641357421875
). 0.05206298828125
▁They 4.69921875
▁were 1.3056640625
▁also 1.41796875
▁an 8.8828125
gu 4.37109375
ished 0.035064697265625
▁em 8.3515625
otion 0.015869140625
ally 0.004215240478515625
▁and 1.138671875
▁react 6.7578125
ed 0.05389404296875
▁rad 9.4453125
ically 0.0079345703125
▁neg 5.42578125
atively 0.0015316009521484375
▁to 0.345458984375
▁almost 5.21484375
▁all 1.2197265625
▁survey 8.4375
▁questions 0.62158203125
. 0.29150390625
▁Pat 4.22265625
ients 0.007663726806640625
▁who 1.154296875
▁took 1.46484375
▁only 5.4765625
▁MM 0.91357421875
▁or 3.173828125
▁mixed 3.3828125
▁medic 2.541015625
ations 0.308837890625
▁course 12.6015625
▁had 2.4609375
▁a 1.2822265625
▁significantly 2.603515625
▁more 4.0546875
▁stable 3.404296875
▁emot 1.1708984375
ional 0.0080718994140625
▁state 0.80712890625
▁and 1.4150390625
▁cop 5.56640625
ed 0.86376953125
▁with 0.73828125
▁pain 1.439453125
▁more 1.6513671875
▁manage 6.9375
able 2.3828125
. 0.52392578125
<0x0A> 0.701171875
One 5.1875
▁of 0.6171875
▁the 0.020843505859375
▁major 2.5390625
▁limitations 2.833984375
▁is 3.96875
▁the 0.50927734375
▁ins 4.7578125
u 0.021240234375
fficient 0.1273193359375
ly 4.625
▁high 3.052734375
▁response 3.0078125
▁rate 0.11993408203125
, 2.646484375
▁ 4.65234375
5 1.91796875
7 2.03515625
% 2.134765625
▁instead 7.2734375
▁of 0.006214141845703125
▁ 0.697265625
7 1.544921875
0 1.4638671875
% 1.1171875
▁( 1.6484375
Fe 0.260009765625
ing 0.004550933837890625
old 0.0008001327514648438
▁et 0.00650787353515625
▁al 0.0015764236450195312
., 0.005329132080078125
▁ 0.00415802001953125
2 0.00043320655822753906
0 3.600120544433594e-05
1 0.0010004043579101562
7 0.00673675537109375
). 0.037445068359375
▁It 2.666015625
▁can 3.287109375
▁bef 13.65625
air 2.6640625
ly 0.0689697265625
▁explained 1.7744140625
▁by 0.152099609375
▁the 0.3857421875
▁weak 8.078125
▁focus 7.17578125
▁of 0.456298828125
▁respond 6.28125
ents 0.1363525390625
▁who 3.54296875
▁have 4.2578125
▁overcome 8.1015625
▁severe 2.392578125
▁pain 0.47705078125
▁sens 8.6796875
ations 1.0908203125
▁and 1.26171875
▁de 4.12890625
press 1.7734375
ive 0.276123046875
▁episodes 4.03515625
. 0.5791015625
▁It 3.29296875
▁is 0.8857421875
▁not 2.60546875
▁clear 4.0859375
▁how 1.7177734375
▁to 3.8359375
▁use 5.3515625
▁these 3.021484375
▁statistics 3.4921875
, 2.55859375
▁as 1.3828125
▁they 1.3349609375
▁still 6.04296875
▁may 4.8671875
▁be 1.3154296875
▁relevant 5.625
▁for 1.421875
▁the 1.8876953125
▁overall 4.54296875
▁analysis 3.072265625
. 1.072265625
